Clinical Trials Browser

OTHER × Observational × HER2-positive Metastatic Breast Cancer × Clear all

NCT06551116 2026-04-07

QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer

HER2-positive Metastatic Breast Cancer

NCT06305702 2024-03-12

Real-world Study of Inetetamab in HER2-positive Metastatic Breast Cancer

HER2-positive Metastatic Breast Cancer

NCT05188495 2022-01-12

HELP

HER2-positive Metastatic Breast Cancer